[HTML][HTML] IL-17 在局部及全身的致关节炎作用: 从发现到靶向治疗
莫颖倩， 毕瑜斐， 戴冽 - 新医学, 2018 - xinyixue.cn
… IL-17 targeted therapy is dedicated to controlling chronic inflammation-related injury or pain.
… This article reviews the entire process of IL-17 from the discovery to the determination of …
… This article reviews the entire process of IL-17 from the discovery to the determination of …
[HTML][HTML] 银屑病的治疗靶点与临床转化研究
刘艺媛， 满孝勇 - 生物医学转化, 2021 - swyxzh.ijournals.cn
… , biologics targeting TNF-α, IL-23, and IL-17 have been … At present, more therapeutic
targets are under research or in … This review summarizes therapeutic targets and biologics of …
targets are under research or in … This review summarizes therapeutic targets and biologics of …
肠道代谢产物通过TAM-TLRs-SOCS 通路对多发性硬化炎性脱髓鞘机制的研究
李晓玲 - 2021 - ir.lzu.edu.cn
… receptor levels in EAE mice and to discover new therapeutic targets by analyzing the negative
… of the inflammatory factors (IFN-γand IL-17) and reducing inflammatory demyelination. 2.…
… of the inflammatory factors (IFN-γand IL-17) and reducing inflammatory demyelination. 2.…
[HTML][HTML] 基于网络药理学探讨黄芩-黄连治疗动脉粥样硬化的作用机制
罗舒文， 俞琦 - Advances in Clinical Medicine, 2022 - hanspub.org
… , there is an urgent clinical need to discover new drugs to treat … two, 14 baicalin and scutellaria
targets were identified for the … Th17细胞释放IL-17 (IL-17 A),这是标志性细胞因子,其结构中…
targets were identified for the … Th17细胞释放IL-17 (IL-17 A),这是标志性细胞因子,其结构中…
Uncovering the action mechanism of Shenqi Tiaoshen formula (参芪调肾方) in the treatment of chronic obstructive pulmonary disease through network pharmacology …
Y Qinjun, YIN Dandan, W Hui… - Journal of …, 2024 - search.ebscohost.com
… target of the compound. Finally, to standardize the information of protein targets, the protein
targets … VEGFA, caspase-3, p-STAT3, and IL-17 in the lung tissues of rats were observed and …
targets … VEGFA, caspase-3, p-STAT3, and IL-17 in the lung tissues of rats were observed and …
Deciphering the chemical profile and pharmacological mechanism of Jinlingzi powder (金铃子散) against bile reflux gastritis using ultra-high performance liquid …
H REN, L ZHAO, K GAO, Y YANG, X CUI… - Journal of Traditional …, 2023 - europepmc.org
… 1, MAPK, FoxO, TNF, and IL-17. The core CTP interaction network was subsequently
constructed by linking 13 bioactive compounds, 24 core targets, and the top ten pathways to further …
constructed by linking 13 bioactive compounds, 24 core targets, and the top ten pathways to further …
[HTML][HTML] Deciphering the chemical profile and pharmacological mechanism of Jinlingzi powder (金铃子散) against bile reflux gastritis using ultra-high performance …
REN Hui, Z Lintao, GAO Kai, Y Yuanyuan… - Journal of Traditional …, 2023 - ncbi.nlm.nih.gov
… 1, MAPK, FoxO, TNF, and IL-17. The core CTP interaction network was subsequently
constructed by linking 13 bioactive compounds, 24 core targets, and the top ten pathways to further …
constructed by linking 13 bioactive compounds, 24 core targets, and the top ten pathways to further …
[HTML][HTML] IL-17 和HSP90 在不同牛肝中的定位和定量研究
赵凯， 崔燕， 刘鹏刚， 何俊峰， 宋亮丽， 廖博， 杨晓晴 - 畜牧兽医学报, 2019 - html.rhhz.net
… of IL-17 and HSP90 in liver tissues of different cattle, and to compare the positive reaction and
differential expression of IL-17 … Both IL-17 and HSP90 were expressed in the cytoplasm of …
differential expression of IL-17 … Both IL-17 and HSP90 were expressed in the cytoplasm of …
[PDF][PDF] 养血透邪法治疗静止期银屑病(血燥证) 的临床疗效评价及对血清IL-17 的影响
王英杰， 姜珠倩， 武宗琴， 刘杰， 罗瑞静， 李淑， 柴维汉… - 世界临床药物, 2022 - jwph.com.cn
… , 中医证候评分,血清IL-17 水平较治疗前均下降,且… IL-17 水平方面,两组比较差异无统计学意义
(P > 0.05).结论养血透邪 法治疗静止期银屑病( 血燥证) 疗效确切,其作用机制可能与下调血清IL-17 …
(P > 0.05).结论养血透邪 法治疗静止期银屑病( 血燥证) 疗效确切,其作用机制可能与下调血清IL-17 …